GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be ...

A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...

Galderma’s nemolizumab has been shown to improve the core signs and symptoms of prurigo nodularis, according to phase 3 ...

AstraZeneca (AZ) has announced a $3.5bn investment in the US aimed at expanding its research and manufacturing footprint by ...

Health equity, a fundamental human right, remains elusive for many. As health communicators, we play a crucial role in addressing these disparities, bridging gaps and supporting underserved ...

The US Food and Drug Administration (FDA) has approved BridgeBio Pharma’s Attruby (acoramidis) to treat adults with ...

Novartis and Ratio Therapeutics have entered into a worldwide licence and collaboration agreement worth $745m to advance a ...

Live meetings have come a long way in recent years, but let’s face it – ‘passive listening’ is a concept best left in the ...

UCB’s Bimzelx (bimekizumab-bkzx) has been approved by the US Food and Drug Administration (FDA) to treat active ...

Ipsen has shared positive three-year results for Iqirvo (elafibranor) in patients with the rare cholestatic liver disease ...

Roche has announced that it will be acquiring Poseida Therapeutics in a deal worth $1.5bn, giving the company access to a ...